| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.061 | 0.8 |